
Computer Programs and Systems Cash Flow 2025-2008 | CPSI
Brief overview of Computer Programs and Systems's cash flow quality
Cash flow changes are traced through the five latest available reports from 2021 to 2025.
Across five available reports, cash from operations decreased from $47.7 million to $37 million, leaving a weaker cash base.
Operating cash flow was above zero 4 times out of five. Most, but not all, periods generated cash.
Operating cash margin decreased to 10.7% from 17% initially. The quality of receipts deteriorated.
Conclusion
Computer Programs and Systems's cash profile looks stretched: weak operating cash flow limits investment, payouts and debt-servicing capacity.
Annual Cash Flow Computer Programs and Systems
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
37 M | 31.1 M | -522 K | 32.4 M | 47.7 M | 49.1 M | 43.6 M | 23.9 M | 23.6 M | 2.1 M | 30.9 M | 39 M | 29 M | 32.2 M | 33.5 M | 19.6 M | 8.81 M | - |
Depreciation & Amortization |
1.09 M | 1.35 M | 1.95 M | 2.44 M | 2.16 M | 1.79 M | 1.41 M | 1.8 M | 2.47 M | 3.06 M | 3.17 M | 3.66 M | 3.43 M | 3.16 M | 2.5 M | 1.85 M | 1.77 M | - |
Accounts Payables |
19.6 M | 15 M | 10.1 M | 7.04 M | 8.08 M | 7.72 M | 8.8 M | 5.67 M | 7.62 M | 6.84 M | 4.59 M | 3.99 M | 3.21 M | 2.98 M | 2.47 M | 2.62 M | - | - |
Accounts Receivables |
55 M | 53 M | 56.2 M | 51.3 M | 34.4 M | 32.4 M | 38.8 M | 40.5 M | 38.1 M | 31.8 M | 22.6 M | 23.1 M | 20.1 M | 19.7 M | 21.5 M | 25.5 M | - | - |
Total Inventories |
623 K | 767 K | 475 K | 784 K | 855 K | 1.08 M | 1.43 M | 1.5 M | 1.42 M | 1.7 M | 1.49 M | 1.43 M | 1.59 M | 1.68 M | 1.84 M | 1.78 M | - | - |
All numbers in USD currency
Quarterly Cash Flow Computer Programs and Systems
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
15.5 M | - | - | 5.76 M | - | - | -2.03 M | - | - | 9.47 M | - | 30.2 M | 19.1 M | 11.8 M | - | 34.5 M | 33.1 M | 13.7 M | - | 33 M | 24.8 M | 7.59 M | - | 25.5 M | - | 17.5 M | - | 14.9 M | 7.82 M | 3.12 M | - | 18.3 M | 15.9 M | 9.69 M | - | -2.57 M | -8.48 M | 834 K | - | 26.3 M | 17.4 M | 13.6 M | - | 26.1 M | 14.5 M | 13.2 M | - | 14.3 M | 6.78 M | 5.52 M | - | 18 M | 11.5 M | 8.55 M | - | 24.2 M | 17.1 M | 14.3 M |
Depreciation & Amortization |
271 K | 243 K | 312 K | 291 K | 279 K | 400 K | 400 K | 297 K | 597 K | 498 K | - | 622 K | 690 K | 578 K | - | 525 K | 563 K | 553 K | - | 1.33 M | 892 K | 420 K | - | 1.08 M | 2.52 M | 730 K | - | 1.42 M | 1.07 M | 529 K | - | 1.94 M | 1.42 M | 718 K | - | 2.42 M | 1.74 M | 852 K | - | 2.5 M | 1.83 M | 911 K | - | 2.73 M | 1.86 M | 930 K | - | 2.56 M | 1.72 M | 850 K | - | 2.34 M | 1.67 M | 819 K | - | 1.77 M | 1.23 M | 609 K |
Accounts Payables |
22.5 M | 20.2 M | 19.7 M | 14.9 M | 14 M | 15.9 M | - | 13.4 M | 14.5 M | 12.6 M | 7.04 M | 7.48 M | 8 M | 7.24 M | 8.08 M | 5.45 M | 6.85 M | 6.74 M | 7.72 M | 7.72 M | 7.72 M | 7.72 M | 8.8 M | 8.8 M | 5.42 M | 8.8 M | 5.67 M | 5.67 M | 5.67 M | 5.67 M | 7.62 M | 7.62 M | 7.62 M | 7.62 M | 6.84 M | 6.84 M | 6.84 M | 6.84 M | 4.59 M | 4.59 M | 4.59 M | 4.59 M | 3.99 M | 3.99 M | 3.99 M | 3.99 M | 3.21 M | 3.21 M | 3.21 M | 3.21 M | 2.98 M | 2.98 M | 2.98 M | 2.98 M | 2.47 M | 2.47 M | 2.47 M | 2.47 M |
Accounts Receivables |
50.9 M | 56.8 M | 56.4 M | 56.6 M | 56.7 M | 59.6 M | - | 59 M | 54.9 M | 54.7 M | 51.3 M | 45.6 M | 48.8 M | 41.5 M | 34.4 M | 30.5 M | 30.9 M | 33.8 M | 32.4 M | 32.4 M | 32.4 M | 32.4 M | 38.8 M | 38.8 M | 37.7 M | 38.8 M | 40.5 M | 40.5 M | 40.5 M | 40.5 M | 38.1 M | 38.1 M | 38.1 M | 38.1 M | 31.8 M | 31.8 M | 31.8 M | 31.8 M | 22.6 M | 22.6 M | 22.6 M | 22.6 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 20.1 M | 20.1 M | 20.1 M | 20.1 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 21.5 M | 21.5 M | 21.5 M | 21.5 M |
Total Inventories |
958 K | 351 K | 444 K | 595 K | 924 K | 793 K | - | 941 K | 962 K | 1.18 M | 784 K | 1.75 M | 1.13 M | 567 K | 855 K | 1.15 M | 1.42 M | 1.34 M | 1.08 M | 1.08 M | 1.08 M | 1.08 M | 1.43 M | 1.43 M | 1.87 M | 1.43 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.42 M | 1.42 M | 1.42 M | 1.42 M | 1.7 M | 1.7 M | 1.7 M | 1.7 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 1.43 M | 1.43 M | 1.43 M | 1.43 M | 1.59 M | 1.59 M | 1.59 M | 1.59 M | 1.68 M | 1.68 M | 1.68 M | 1.68 M | 1.84 M | 1.84 M | 1.84 M | 1.84 M |
All numbers in USD currency
Cash Flow Statement is one of the three key financial reports of the company Computer Programs and Systems, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.
Main Sections of the Cash Flow Statement- Operating Activities
This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash. - Investing Activities
Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign. - Financing Activities
Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.
The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.
Cash flow statements of other stocks in the Health information services sector
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Cerner Corporation
CERN
|
- | - | $ 27.9 B | ||
|
Accolade
ACCD
|
- | 0.29 % | $ 206 M | ||
|
Change Healthcare
CHNG
|
- | - | $ 9.03 B | ||
|
Covetrus
CVET
|
- | - | $ 2.94 B | ||
|
So-Young International
SY
|
$ 1.84 | 0.55 % | $ 143 M | ||
|
iCAD
ICAD
|
- | - | $ 102 M | ||
|
HealthEquity
HQY
|
$ 100.61 | -0.38 % | $ 8.67 B | ||
|
Akerna Corp.
KERN
|
- | - | $ 161 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
- | -10.39 % | $ 886 M | ||
|
MTBC
MTBC
|
- | -0.58 % | $ 51.7 M | ||
|
Zhongchao
ZCMD
|
$ 1.13 | -11.72 % | $ 3.86 M | ||
|
1Life Healthcare
ONEM
|
- | - | $ 3.37 B | ||
|
NextGen Healthcare
NXGN
|
- | - | $ 1.6 B | ||
|
Premier
PINC
|
- | - | $ 2.33 B | ||
|
American Well Corporation
AMWL
|
$ 10.75 | -0.83 % | $ 173 M | ||
|
R1 RCM
RCM
|
- | - | $ 3.81 B | ||
|
Signify Health
SGFY
|
- | -0.02 % | $ 7.21 B | ||
|
Streamline Health Solutions
STRM
|
- | - | $ 21.4 M | ||
|
NantHealth
NH
|
- | -46.64 % | $ 10.4 M | ||
|
SCWorx Corp.
WORX
|
- | - | $ 7.71 M | ||
|
Tabula Rasa HealthCare
TRHC
|
- | - | $ 255 M | ||
|
OptimizeRx Corporation
OPRX
|
$ 6.05 | -3.51 % | $ 112 M | ||
|
Progyny
PGNY
|
$ 31.13 | -1.14 % | $ 2.65 B | ||
|
Phreesia
PHR
|
$ 10.73 | 1.13 % | $ 641 M | ||
|
GoodRx Holdings
GDRX
|
$ 3.07 | -3.15 % | $ 1.09 B | ||
|
Schrödinger
SDGR
|
$ 15.14 | -1.37 % | $ 1.11 B | ||
|
Omnicell
OMCL
|
$ 35.37 | -4.69 % | $ 1.63 B | ||
|
Health Catalyst
HCAT
|
$ 2.09 | 0.48 % | $ 146 M | ||
|
HealthStream
HSTM
|
$ 28.04 | -0.57 % | $ 842 M | ||
|
Evolent Health
EVH
|
$ 3.09 | -2.83 % | $ 353 M | ||
|
Teladoc Health
TDOC
|
$ 6.71 | 2.05 % | $ 1.18 B | ||
|
10x Genomics
TXG
|
$ 47.27 | -4.37 % | $ 5.9 B | ||
|
Veeva Systems
VEEV
|
$ 203.78 | 1.1 % | $ 33.4 B |